189 related articles for article (PubMed ID: 16182110)
1. Reduced mRNA and protein content of rho guanine nucleotide exchange factor (RhoGEF) in Bartter's and Gitelman's syndromes: relevance for the pathophysiology of hypertension.
Pagnin E; Semplicini A; Sartori M; Pessina AC; Calò LA
Am J Hypertens; 2005 Sep; 18(9 Pt 1):1200-5. PubMed ID: 16182110
[TBL] [Abstract][Full Text] [Related]
2. Silencing regulator of G protein signaling-2 (RGS-2) increases angiotensin II signaling: insights into hypertension from findings in Bartter's/Gitelman's syndromes.
Calò LA; Pagnin E; Ceolotto G; Davis PA; Schiavo S; Papparella I; Semplicini A; Pessina AC
J Hypertens; 2008 May; 26(5):938-45. PubMed ID: 18398336
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II signaling via type 2 receptors in a human model of vascular hyporeactivity: implications for hypertension.
Calò LA; Schiavo S; Davis PA; Pagnin E; Mormino P; D'Angelo A; Pessina AC
J Hypertens; 2010 Jan; 28(1):111-8. PubMed ID: 19797979
[TBL] [Abstract][Full Text] [Related]
4. Rho kinase and PAI-1 in Bartter's/Gitelman's syndromes: relationship to angiotensin II signaling.
Pagnin E; Davis PA; Sartori M; Semplicini A; Pessina AC; Calò LA
J Hypertens; 2004 Oct; 22(10):1963-9. PubMed ID: 15361768
[TBL] [Abstract][Full Text] [Related]
5. Expression and functional role of the RhoA/Rho-kinase pathway in rat coeliac artery.
Teixeira CE; Jin L; Ying Z; Palmer T; Priviero FB; Webb RC
Clin Exp Pharmacol Physiol; 2005 Oct; 32(10):817-24. PubMed ID: 16173942
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of regulator of G protein signaling-2 (RGS-2) in Bartter's/Gitelman's syndrome. A role in the control of vascular tone and implication for hypertension.
Calò LA; Pagnin E; Davis PA; Sartori M; Ceolotto G; Pessina AC; Semplicini A
J Clin Endocrinol Metab; 2004 Aug; 89(8):4153-7. PubMed ID: 15292363
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II up-regulates the leukemia-associated Rho guanine nucleotide exchange factor (RhoGEF), a regulator of G protein signaling domain-containing RhoGEF, in vascular smooth muscle cells.
Ying Z; Jin L; Palmer T; Webb RC
Mol Pharmacol; 2006 Mar; 69(3):932-40. PubMed ID: 16354763
[TBL] [Abstract][Full Text] [Related]
8. Increased level of p63RhoGEF and RhoA/Rho kinase activity in hypertensive patients.
Calò LA; Davis PA; Pagnin E; Dal Maso L; Maiolino G; Seccia TM; Pessina AC; Rossi GP
J Hypertens; 2014 Feb; 32(2):331-8. PubMed ID: 24356540
[TBL] [Abstract][Full Text] [Related]
9. Early markers of inflammation in a high angiotensin II state--results of studies in Bartter's/Gitelman's syndromes.
Davis PA; Mussap M; Pagnin E; Bertipaglia L; Savica V; Semplicini A; Calò LA
Nephrol Dial Transplant; 2006 Jun; 21(6):1697-701. PubMed ID: 16574683
[TBL] [Abstract][Full Text] [Related]
10. Increased endothelial nitric oxide synthase mRNA level in Bartter's and Gitelman's syndrome. Relationship to vascular reactivity.
Calò L; Davis PA; Milani M; Cantaro S; Antonello A; Favaro S; D'Angelo A
Clin Nephrol; 1999 Jan; 51(1):12-7. PubMed ID: 9988141
[TBL] [Abstract][Full Text] [Related]
11. Absence of vascular remodelling in a high angiotensin-II state (Bartter's and Gitelman's syndromes): implications for angiotensin II signalling pathways.
Calò LA; Puato M; Schiavo S; Zanardo M; Tirrito C; Pagnin E; Balbi G; Davis PA; Palatini P; Pauletto P
Nephrol Dial Transplant; 2008 Sep; 23(9):2804-9. PubMed ID: 18344243
[TBL] [Abstract][Full Text] [Related]
12. A case of Gitelman's syndrome with decreased angiotensin II-forming activity.
Eto K; Onaka U; Tsuchihashi T; Hirano T; Nakayama M; Masutani K; Hirakata H; Urata H; Yasujima M
Hypertens Res; 2006 Jul; 29(7):545-9. PubMed ID: 17044667
[TBL] [Abstract][Full Text] [Related]
13. Oxidative stress-related factors in Bartter's and Gitelman's syndromes: relevance for angiotensin II signalling.
Calò LA; Pagnin E; Davis PA; Sartori M; Semplicini A
Nephrol Dial Transplant; 2003 Aug; 18(8):1518-25. PubMed ID: 12897089
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic approach to the pathophysiology of target organ damage in hypertension from studies in a human model with characteristics opposite to hypertension: Bartter's and Gitelman's syndromes.
Calò LA; Maiolino G
J Endocrinol Invest; 2015 Jul; 38(7):711-6. PubMed ID: 25740064
[TBL] [Abstract][Full Text] [Related]
15. [Role of Rho-Rock pathways induced by angiotensin II in hepatic stellate cell contraction].
Zhang XL; Xiao B; Li X; Huang ML; Meng Y; Li YF; Wang YY; Song WB
Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(34):2422-6. PubMed ID: 19087721
[TBL] [Abstract][Full Text] [Related]
16. Expression of RHOGTPase regulators in human myometrium.
O'Brien M; Flynn D; Mullins B; Morrison JJ; Smith TJ
Reprod Biol Endocrinol; 2008 Jan; 6():1. PubMed ID: 18190708
[TBL] [Abstract][Full Text] [Related]
17. SIRT1, heme oxygenase-1 and NO-mediated vasodilation in a human model of endogenous angiotensin II type 1 receptor antagonism: implications for hypertension.
Davis PA; Pagnin E; Dal Maso L; Caielli P; Maiolino G; Fusaro M; Paolo Rossi G; Calò LA
Hypertens Res; 2013 Oct; 36(10):873-8. PubMed ID: 23698802
[TBL] [Abstract][Full Text] [Related]
18. Gitelman's syndrome (familial hypokalemia-hypomagnesemia).
Barakat AJ; Rennert OM
J Nephrol; 2001; 14(1):43-7. PubMed ID: 11281344
[TBL] [Abstract][Full Text] [Related]
19. Gαq/p63RhoGEF interaction in RhoA/Rho kinase signaling: investigation in Gitelman's syndrome and implications with hypertension.
Pagnin E; Ravarotto V; Maiolino G; Naso E; Davis PA; Calò LA
J Endocrinol Invest; 2018 Mar; 41(3):351-356. PubMed ID: 28840514
[TBL] [Abstract][Full Text] [Related]
20. ACE2 and angiotensin 1-7 are increased in a human model of cardiovascular hyporeactivity: pathophysiological implications.
Calò LA; Schiavo S; Davis PA; Pagnin E; Mormino P; D'Angelo A; Pessina AC
J Nephrol; 2010; 23(4):472-7. PubMed ID: 20349406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
